Company
Asensus Surgical
Asensus Surgical is an American surgical robotics company based in Durham, North Carolina, developing the Senhance robotic surgical system for minimally…
- Founded
- 2006
- HQ
- Durham, NC
- Status
- acquired by Karl Storz (Aug 2024; ~$95M; delisted)
- Models
- 1
Verified profile
4
Sources on record
1
Tracked changes
Updated 1 month ago
Last verified change
Overview
Asensus Surgical is an American surgical robotics company based in Durham, North Carolina, developing the Senhance robotic surgical system for minimally invasive abdominal surgery, with AI-powered surgical intelligence and augmented reality visualization.
Verified record
- Verified deployments
- None on file
- Active incidents
- 2 incidents on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Models (1)
View all models →Current leadership (1)
- Shameze Rampertab EVP & Chief Financial Officerreported, not verified
Former / Previously (1)
- Anthony Fernando President & CEO (at acquisition)secondary-verified
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Incidents affecting Asensus Surgical (2)
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Peer companies
- Intuitive Surgical2 models
- Johnson & Johnson2 models
- Stryker2 models
- Vantis2 models
- Auris Health1 model
- Brain Navi1 model
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- acquired
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Regulatory filings (2)
- fda_recallfda recall · us_fdarecalled2023-09-15
Linked models: Senhance
- K171120fda 510k · us_fdacleared2017-04-14
Linked models: Senhance
Acquisitions (1)
- acquired by Karl Storz SE & Co. KGfull acquisition
Sources (4)
- https://www.globenewswire.com/news-release/2024/08/22/asensus-surgical-karl-storz-closing
- https://www.massdevice.com/asensus-surgical-karl-storz-acquisition/
- https://www.urologytimes.com/view/transenterix-senhance-fda-clearance
- https://www.therobotreport.com/karl-storz-closes-acquisition-of-asensus-surgical/
Common questions
- What is Asensus Surgical?
- Asensus Surgical is an American surgical robotics company based in Durham, North Carolina, developing the Senhance robotic surgical system for minimally invasive abdominal surgery, with AI-powered surgical intelligence and augmented reality visualization.
- Where is Asensus Surgical based?
- Asensus Surgical is based in Durham, NC.
- When was Asensus Surgical founded?
- Asensus Surgical was founded in 2006.
- What does Asensus Surgical make?
- Asensus Surgical has 1 robot model on the DEPLOY registry: Senhance (Asensus Surgical builds both physical robots and the AI that runs them).
- Where does Asensus Surgical operate robots?
- Asensus Surgical is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Are there any incidents involving Asensus Surgical?
- 2 active incidents involving Asensus Surgical are on the DEPLOY registry. Each is a sourced, append-only record; retracted incidents are suppressed from this view.
- Is Asensus Surgical safe?
- Asensus Surgical has 2 active incidents on record in the DEPLOY registry. 2 recalls on record (2 critical). Most recent: Sep 2023. Retracted incidents are excluded from this count.
Methodology: Verified · 4 sources (1 primary) · last reviewed 2026-07-03
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-07-03
Sources by quality tier
- 2
- unclassified
- Unclassified source
- 1
- primary-company-ir
- Company IR disclosure
- 1
- secondary-trade-publication
- Trade publication
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Asensus Surgical.Peer companies
- Intuitive Surgical2 models
- Johnson & Johnson2 models
- Stryker2 models
- Vantis2 models
- Auris Health1 model
- Brain Navi1 model
Machine-readable surfaces
- Markdown mirror: /companies/asensus-surgical.md
- RSS feed: /companies/asensus-surgical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/a3a097cb-a5db-4ffd-b421-5eb14335dbcf
- Revision history: /companies/asensus-surgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Intuitive Surgical2 models
- Johnson & Johnson2 models
- Stryker2 models
- Vantis2 models
- Auris Health1 model
- Brain Navi1 model
DEPLOY Intelligence Score
17.2/ 100
6-month trend
Analysis
Safety profile within acceptable range for category. Limited public visibility and press coverage relative to peers.
Signal flags
Dimension breakdown
Safety Record
Deployment Scale
IP Activity
Funding Health
Hiring Signal
Market Presence
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
Last computed: Jul 3, 2026
Intelligence layer